This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by NIEMAN, L. K. Articles by CHROUSOS, G. P. Search for Related Content PubMed PubMed Citation Articles by NIEMAN, L. K. Articles by CHROUSOS, G. P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Cushing's Syndrome Hazardous Substances DB HYDROCORTISONE

The Ovine Corticotropin-Releasing Hormone (CRH) Stimulation Test Is Superior to the Human CRH Stimulation Test for the Diagnosis of Cushing's Disease

Developmental Endocrinology Branch, National Institute of Child Health and Human Development Bethesda, Maryland 20892
Clinical Neurosurgery Section, the Surgical Neurology Branch, National Institute of Neurological and Communicative Disorders and Stroke Bethesda, Maryland 20892
National Institutes of Health Bethesda, Maryland 20892

Address all correspondence and requests for reprints to: Dr. Lynnette Nieman, Building 10, Room 10N262, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892.

The ovine CRH (oCRH) stimulation test is useful in distinguishing Cushing's disease from the syndrome of ectopic ACTH secretion. Most patients with Cushing's disease have increased plasma ACTH and cortisol responses to oCRH, while patients with the ectopic ACTH syndrome do not. We predicted that the homologous hormone human CRH (hCRH) might be an equally useful diagnostic agent, with the theoretic advantage of being less immunogenic. This study compared the responses to hCRH and oCRH (1 µg/kg, iv) in 15 patients with Cushing's disease. Plasma ACTH and cortisol levels increased in most patients during the first hour after administration of either hCRH or oCRH. However, the peak and time-integrated hormonal responses to hCRH were smaller than the responses to oCRH. All but 1 patient had an ACTH and/or cortisol response to oCRH that exceeded 4 times the intraassay coefficient of variation. Three patients had neither an ACTH nor a cortisol response to hCRH by the same criterion. Thus, when administered at equivalent doses, hCRH is a less effective stimulus of ACTH and cortisol secretion in patients with Cushing's disease. Based upon the observation that the oCRH stimulation test has greater sensitivity than the hCRH stimulation test for the diagnosis of Cushing's disease, we conclude that oCRH is the preferred analog to use for CRH testing in patients with Cushing's syndrome.

Received November 2, 1988.

This article has been cited by other articles:

				G. Arnaldi, G. Tirabassi, R. Papa, G. Furlani, L. Trementino, M. Cardinaletti, E. Faloia, and M. Boscaro Human corticotropin releasing hormone test performance in the differential diagnosis between Cushing's disease and pseudo-Cushing state is enhanced by combined ACTH and cortisol analysis Eur. J. Endocrinol., June 1, 2009; 160(6): 891 - 898. [Abstract] [Full Text] [PDF]

				L. K. Nieman, B. M. K. Biller, J. W. Findling, J. Newell-Price, M. O. Savage, P. M. Stewart, and V. M. Montori The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1526 - 1540. [Abstract] [Full Text] [PDF]

				J. Newell-Price, D. G. Morris, W. M. Drake, M. Korbonits, J. P. Monson, G. M. Besser, and A. B. Grossman Optimal Response Criteria for the Human CRH Test in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1640 - 1645. [Abstract] [Full Text] [PDF]

				S. Tsagarakis, C. Tsigos, V. Vasiliou, P. Tsiotra, J. Kaskarelis, C. Sotiropoulou, S. A. Raptis, and N. Thalassinos The Desmopressin and Combined CRH-Desmopressin Tests in the Differential Diagnosis of ACTH-Dependent Cushing's Syndrome: Constraints Imposed by the Expression of V2 Vasopressin Receptors in Tumors with Ectopic ACTH Secretion J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1646 - 1653. [Abstract] [Full Text] [PDF]

				M. I. Wiggam, A. P. Heaney, E. M. McIlrath, D. R. McCance, B. Sheridan, D. R. Hadden, and A. B. Atkinson Bilateral Inferior Petrosal Sinus Sampling in the Differential Diagnosis of Adrenocorticotropin-Dependent Cushing's Syndrome: A Comparison with Other Diagnostic Tests J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1525 - 1532. [Abstract] [Full Text]

				J. Newell-Price, P. Trainer, M. Besser, and A. Grossman The Diagnosis and Differential Diagnosis of Cushing's Syndrome and Pseudo-Cushing's States Endocr. Rev., October 1, 1998; 19(5): 647 - 672. [Abstract] [Full Text]

				M. A. Magiakou, G. Mastorakos, E. H. Oldfield, M. T. Gomez, J. L. Doppman, G. B. Cutler, L. K. Nieman, and G. P. Chrousos Cushing's Syndrome in Children and Adolescents -- Presentation, Diagnosis, and Therapy N. Engl. J. Med., September 8, 1994; 331(10): 629 - 636. [Abstract] [Full Text]

				T. B. Kaye and L. Crapo The Cushing Syndrome: An Update on Diagnostic Tests Ann Intern Med, March 15, 1990; 112(6): 434 - 444. [Abstract] [PDF]